Improving Provider Adherence to Guideline Recommendations in Heart Failure

Katherine E Di Palo1, Ileana L Piña2, Hector O Ventura3

  • 1Department of Cardiology, Montefiore Medical Center, 1825 Eastchester Road, Bronx, NY, 10461, USA. kdipalo@montefiore.org.

Insights

Adherence to heart failure guidelines, especially medication, is low. Implementing multidisciplinary care and standardizing referrals can improve patient outcomes and quality of life for heart failure patients.

Area of Science:

  • Cardiology
  • Clinical Practice Guidelines
  • Evidence-Based Medicine

Background:

  • Clinical practice guidelines for heart failure (HF) are essential for evidence-based care and improved patient outcomes.
  • However, adherence to these guidelines, particularly guideline-directed medical therapy (GDMT), remains suboptimal.

Purpose of the Study:

  • To review current challenges and strategies for improving adherence to heart failure clinical practice guidelines.
  • To highlight the impact of suboptimal adherence on patient outcomes and quality of life.

Main Methods:

  • Review of recent clinical trials, updated guidelines, and expert consensus statements.
  • Analysis of registry data on pharmacotherapy and device implantation in heart failure patients.
  • Examination of strategies to enhance provider adherence to HF guidelines.

Main Results:

  • Registry data indicate that many heart failure patients do not receive appropriate pharmacotherapy.
  • Patients may receive intracardiac devices before initiation or optimization of medical therapy.
  • Multidisciplinary models, appropriate referrals, and care standardization are identified as key strategies for improvement.

Conclusions:

  • Improving adherence to heart failure guidelines is critical for optimizing patient care.
  • Implementing structured approaches like multidisciplinary care can significantly reduce morbidity and mortality.
  • Enhanced adherence to guideline-directed medical therapy can improve the quality of life for heart failure patients.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
948
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.7K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
903
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
348
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
981
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
329